NAISS
SUPR
NAISS Projects
SUPR
Governance of role conflicts in community pharmacy management
Dnr:

sens2026002

Type:

NAISS SENS

Principal Investigator:

Elin Lehnbom

Affiliation:

Uppsala universitet

Start Date:

2026-02-04

End Date:

2026-09-01

Primary Classification:

30301: Health Care Service and Management, Health Policy and Services and Health Economy

Webpage:

Allocation

Abstract

This project investigates how senior management in Swedish community pharmacy organisations perceive, prevent, and manage role conflicts between Pharmacy Managers (PM) and the legally designated Quality Assurance Pharmacist (QAP). The aim is to generate new insights into how governance structures, leadership practices, and organisational priorities shape role expectations and potential tensions within pharmacy operations. The study addresses an understudied but increasingly relevant challenge in the modern pharmacy sector: the balancing of economic efficiency, regulatory compliance, and high‑quality pharmaceutical care. Using a qualitative design, the project will conduct in‑depth, semi‑structured interviews with members of the corporate management team(s) responsible for quality, operations, compliance, and organisational governance in major Swedish pharmacy chains. The data will be interpreted through the lens of "role theory", focusing on concepts such as role expectations, role clarity, inter‑role conflict, and intra‑role conflict. The anticipated outcome is a deeper understanding of how role conflicts are constructed and handled at a strategic level, which governance mechanisms support effective collaboration, and what organisational levers may reduce role stress and strengthen quality performance. The results will have relevance for pharmacy management, regulatory stakeholders, and professional groups seeking to optimise the conditions for safe and efficient pharmaceutical services. The project has no external funding. Data collection and analysis will be conducted between 1 January 2026 and 30 June 2026. Ethical considerations include informed consent, confidentiality, anonymisation of organisations and individuals, and secure handling of interview recordings and transcripts.